Logo image of ABTS

ABITS GROUP INC (ABTS) Stock Fundamental Analysis

NASDAQ:ABTS - Nasdaq - VGG6S34K1136 - Common Stock - Currency: USD

4.62  0 (0%)

Fundamental Rating

3

ABTS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. While ABTS seems to be doing ok healthwise, there are quite some concerns on its profitability. ABTS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ABTS had negative earnings in the past year.
In the past year ABTS had a positive cash flow from operations.
ABTS had negative earnings in 4 of the past 5 years.
In multiple years ABTS reported negative operating cash flow during the last 5 years.
ABTS Yearly Net Income VS EBIT VS OCF VS FCFABTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

ABTS's Return On Assets of -8.00% is in line compared to the rest of the industry. ABTS outperforms 43.26% of its industry peers.
ABTS has a Return On Equity (-8.76%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -8%
ROE -8.76%
ROIC N/A
ROA(3y)-65.96%
ROA(5y)-46.05%
ROE(3y)-70%
ROE(5y)-46.84%
ROIC(3y)N/A
ROIC(5y)N/A
ABTS Yearly ROA, ROE, ROICABTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50K 100K

1.3 Margins

ABTS has a Gross Margin of 50.30%. This is in the lower half of the industry: ABTS underperforms 67.73% of its industry peers.
ABTS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ABTS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.84%
ABTS Yearly Profit, Operating, Gross MarginsABTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

5

2. Health

2.1 Basic Checks

ABTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ABTS has about the same amout of shares outstanding than it did 1 year ago.
ABTS has more shares outstanding than it did 5 years ago.
ABTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ABTS Yearly Shares OutstandingABTS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
ABTS Yearly Total Debt VS Total AssetsABTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

ABTS has an Altman-Z score of -2.79. This is a bad value and indicates that ABTS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.79, ABTS is doing worse than 80.14% of the companies in the same industry.
There is no outstanding debt for ABTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.79
ROIC/WACCN/A
WACC11.06%
ABTS Yearly LT Debt VS Equity VS FCFABTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.69 indicates that ABTS should not have too much problems paying its short term obligations.
The Current ratio of ABTS (1.69) is comparable to the rest of the industry.
ABTS has a Quick Ratio of 1.69. This is a normal value and indicates that ABTS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.69, ABTS is in line with its industry, outperforming 53.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
ABTS Yearly Current Assets VS Current LiabilitesABTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 92.77% over the past year.
ABTS shows a strong growth in Revenue. In the last year, the Revenue has grown by 299.12%.
ABTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 78.53% yearly.
EPS 1Y (TTM)92.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.14%
Revenue 1Y (TTM)299.12%
Revenue growth 3Y212.79%
Revenue growth 5Y78.53%
Sales Q2Q%81.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABTS Yearly Revenue VS EstimatesABTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABTS. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABTS Price Earnings VS Forward Price EarningsABTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

95.39% of the companies in the same industry are more expensive than ABTS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.62
ABTS Per share dataABTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ABTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ABITS GROUP INC

NASDAQ:ABTS (7/25/2025, 8:00:00 PM)

4.62

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.64%
Inst Owner ChangeN/A
Ins Owners11.94%
Ins Owner ChangeN/A
Market Cap10.95M
AnalystsN/A
Price TargetN/A
Short Float %4.46%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.63
P/FCF N/A
P/OCF 5.71
P/B 1.05
P/tB 1.05
EV/EBITDA 7.62
EPS(TTM)-0.38
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.81
OCFY17.51%
SpS2.83
BVpS4.38
TBVpS4.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8%
ROE -8.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.3%
FCFM N/A
ROA(3y)-65.96%
ROA(5y)-46.05%
ROE(3y)-70%
ROE(5y)-46.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-12.84%
F-Score6
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 98.87%
Cap/Sales 38.69%
Interest Coverage N/A
Cash Conversion 148.62%
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z -2.79
F-Score6
WACC11.06%
ROIC/WACCN/A
Cap/Depr(3y)268.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)6827.89%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)299.12%
Revenue growth 3Y212.79%
Revenue growth 5Y78.53%
Sales Q2Q%81.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y74.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.18%
OCF growth 3YN/A
OCF growth 5YN/A